Asian Phytoceuticals PCL (BKK: APCO)

Asian Phytoceuticals PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Jan 1, 2020
Cash & Equivalents	215.8	125.63	82.15	98.59	100.2	160.28
Short-Term Investments	42.08	102.01	61.25	32.23	0.53	319.51
Trading Asset Securities	4.61	23.54	35.75	36.09	71.3	-
Cash & Short-Term Investments	262.49	251.19	179.15	166.92	172.04	479.79
Cash Growth	21.91%	40.21%	7.33%	-2.98%	-64.14%	-3.22%
Accounts Receivable	2.52	0.89	0.98	0.54	1.75	0.91
Other Receivables	2.43	3.34	3.23	2.74	3.54	0.53
Receivables	4.94	4.22	4.21	3.29	5.29	1.44
Inventory	47.47	44.27	52.88	59.94	62.33	62.28
Prepaid Expenses	1.24	0.9	0.92	0.67	0.71	0.66
Other Current Assets	0.25	0.23	0.35	0.3	0.35	0.35
Total Current Assets	316.39	300.82	237.51	231.11	240.72	544.52
Property, Plant & Equipment	74.67	82.34	64.02	91.21	113.39	71.36
Long-Term Investments	204.64	303.86	365.01	346.73	331.93	3.61
Other Intangible Assets	0.69	0.79	0.24	0.36	0.5	0.66
Long-Term Deferred Tax Assets	12.5	10.75	7.11	5.05	4.16	4.03
Other Long-Term Assets	6.13	6.17	6.25	6.07	6.08	5.58
Total Assets	615.03	704.72	680.15	680.53	696.78	629.76
Accounts Payable	1.57	1.2	0.64	1.99	0.63	0.69
Accrued Expenses	15.97	16.47	14.46	14.07	16.87	19.35
Current Portion of Leases	13.51	13.45	12.2	18.74	18.42	-
Current Income Taxes Payable	7.48	10.77	12.7	9.64	9.01	7.86
Current Unearned Revenue	0.26	0.26	0.31	0.32	0.26	0.26
Other Current Liabilities	2.9	4.05	4.78	2.99	3.68	3.04
Total Current Liabilities	41.68	46.2	45.1	47.75	48.87	31.2
Long-Term Leases	17.6	22.22	1.62	15.49	31.59	-
Other Long-Term Liabilities	4.04	4.04	4.04	5.01	3.4	3.4
Total Liabilities	84.04	92.34	69.64	85.54	101.31	50.57
Common Stock	300	300	300	300	300	300
Additional Paid-In Capital	166.94	166.94	166.94	166.94	166.94	166.94
Retained Earnings	85.7	161.63	146.3	126.75	125.26	112.25
Comprehensive Income & Other	-24.84	-18.88	-5.27	1.3	3.26	-
Total Common Equity	527.8	609.7	607.98	594.99	595.46	579.19
Minority Interest	3.19	2.69	2.53	-	-	-
Shareholders' Equity	531	612.39	610.51	594.99	595.46	579.19
Total Liabilities & Equity	615.03	704.72	680.15	680.53	696.78	629.76
Total Debt	31.1	35.67	13.82	34.23	50.01	-
Net Cash (Debt)	231.39	215.52	165.33	132.69	122.02	479.79
Net Cash Growth	10.57%	30.36%	24.60%	8.74%	-74.57%	-3.22%
Net Cash Per Share	0.38	0.36	0.28	0.22	0.20	0.80
Filing Date Shares Outstanding	600	600	600	600	600	600
Total Common Shares Outstanding	600	600	600	600	600	600
Working Capital	274.71	254.62	192.42	183.36	191.84	513.33
Book Value Per Share	0.88	1.02	1.01	0.99	0.99	0.97
Tangible Book Value	527.11	608.91	607.74	594.64	594.96	578.53
Tangible Book Value Per Share	0.88	1.01	1.01	0.99	0.99	0.96
Land	-	8.29	8.29	8.29	8.29	8.29
Buildings	-	93.72	91.07	91.04	94.77	94.31
Machinery	-	82.71	82.49	82.74	86.03	82.3

Source: S&P Capital IQ. Standard template. Financial Sources.